Cargando…

Corrigendum: Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome?

Detalles Bibliográficos
Autores principales:	He, Jia-Wei, Cui, Dong-Feng, Zhou, Xu-Jie, Chen, Pei, Li, Yang, Zhang, Xue, Wang, Yan-Na, Gan, Ting, Liu, Li-Jun, Shi, Su-Fang, Zhu, Li, Hou, Ping, Lv, Ji-Cheng, Zhang, Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289229/ https://www.ncbi.nlm.nih.gov/pubmed/37359520 http://dx.doi.org/10.3389/fimmu.2023.1218427

Ejemplares similares

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
por: He, Jia-Wei, et al.
Publicado: (2022)

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy
por: Chen, Pei, et al.
Publicado: (2018)

Complement Activation Is Associated With Crescents in IgA Nephropathy
por: Wang, Zi, et al.
Publicado: (2021)

Comparison of prognostic, clinical, and renal histopathological characteristics of overlapping idiopathic membranous nephropathy and IgA nephropathy versus idiopathic membranous nephropathy
por: Chen, Xinxin, et al.
Publicado: (2017)

Secondary IgA Nephropathy Shares the Same Immune Features With Primary IgA Nephropathy
por: Wang, Manliu, et al.
Publicado: (2019)

Overlap of Granulomatosis With Polyangiitis and IgA Nephropathy
por: Zeidan, Bassem S, et al.
Publicado: (2021)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
por: Nihei, Yoshihito, et al.
Publicado: (2023)

Concurrent Anti-glomerular Basement Membrane Nephritis and IgA Nephropathy
por: Suh, Kwang-Sun, et al.
Publicado: (2019)

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
por: Knoppova, Barbora, et al.
Publicado: (2016)

Machine learning in predicting T-score in the Oxford classification system of IgA nephropathy
por: Xu, Lin-Lin, et al.
Publicado: (2023)

Immunoproteasome in IgA Nephropathy: State-of-Art and Future Perspectives
por: Gan, Ting, et al.
Publicado: (2020)

Urinary complement profile in IgA nephropathy and its correlation with the clinical and pathological characteristics
por: Wang, Dongqing, et al.
Publicado: (2023)

IgA nephropathy combined with thin basement membrane nephropathy in children
Publicado: (2013)

IgA nephropathy with leucocytoclastic vasculitis
por: Wei, Lin-Yan, et al.
Publicado: (2018)

microRNA-630 Regulates Underglycosylated IgA1 Production in the Tonsils by Targeting TLR4 in IgA Nephropathy
por: Liu, Chan, et al.
Publicado: (2020)

The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
por: Zhao, Na, et al.
Publicado: (2012)

Monitoring Immune Responses in IgA Nephropathy: Biomarkers to Guide Management
por: Selvaskandan, Haresh, et al.
Publicado: (2020)

The role of mononuclear phagocyte system in IgA nephropathy: pathogenesis and prognosis
por: Liu, Yiwen, et al.
Publicado: (2023)

Corrigendum: Plasma exosomal IRAK1 can be a potential biomarker for predicting the treatment response to renin-angiotensin system inhibitors in patients with IgA nephropathy
por: Wu, Jianping, et al.
Publicado: (2022)

A Partial Picture of the Single-Cell Transcriptomics of Human IgA Nephropathy
por: Tang, Rong, et al.
Publicado: (2021)

Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status
por: Gong, Shaomin, et al.
Publicado: (2021)

A Validation Study Comparing Risk Prediction Models of IgA Nephropathy
por: Ouyang, Yan, et al.
Publicado: (2021)

The Role of Complement in Microangiopathic Lesions of IgA Nephropathy
por: Li, Jingyi, et al.
Publicado: (2022)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Alternative Complement Pathway Is Activated and Associated with Galactose-Deficient IgA(1) Antibody in IgA Nephropathy Patients
por: Chiu, Yen-Ling, et al.
Publicado: (2021)

Diagnostic and prognostic value of galactose-deficient IgA1 in patients with IgA nephropathy: an updated systematic review with meta-analysis
por: Zeng, Qin, et al.
Publicado: (2023)

Experimental IgA nephropathy
Publicado: (1979)

Sulodexide in IgA nephropathy
Publicado: (2013)

T lymphocytes in IgA nephropathy
por: Tang, Yuyan, et al.
Publicado: (2020)

Clinicopathologic comparisons of IgA nephropathy and IgA vasculitis nephropathy in children: a ten-year single-center experience
por: SU, QingXiao, et al.
Publicado: (2021)

Increased APRIL Expression Induces IgA1 Aberrant Glycosylation in IgA Nephropathy
por: Zhai, Ya-Ling, et al.
Publicado: (2016)

Corrigendum: Orange-derived and dexamethasone-encapsulated extracellular vesicles reduced proteinuria and alleviated pathological lesions in IgA nephropathy by targeting intestinal lymphocytes
por: Zhang, Wang, et al.
Publicado: (2022)

Validation of the International IgA Nephropathy Prediction Tool in the Greek Registry of IgA Nephropathy
por: Papasotiriou, Marios, et al.
Publicado: (2022)

Immune Characteristics of IgA Nephropathy With Minimal Change Disease
por: Li, Huixian, et al.
Publicado: (2021)

A Rare Genetic Defect of MBL2 Increased the Risk for Progression of IgA Nephropathy
por: Ouyang, Yan, et al.
Publicado: (2019)

Genetic Risk Factors in Lupus Nephritis and IgA Nephropathy – No Support of an Overlap
por: Vuong, Mai Tuyet, et al.
Publicado: (2010)

Clinical and pathological characteristics in elderly patients with IgA nephropathy
por: Zhang, Yongji, et al.
Publicado: (2023)

Myeloid bodies caused by COQ2 mutation: a case of concurrent COQ2 nephropathy and IgA nephropathy
por: Ni, Hai-Feng, et al.
Publicado: (2021)

The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy
por: Rizk, Dana V., et al.
Publicado: (2019)

Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy
por: Zachova, Katerina, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_hf8g2grgacgrsc4m48pjg2h3sd